Provectus Biopharmaceuticals, Inc.
PVCT- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000315545
No open-market purchases or sales by Provectus Biopharmaceuticals, Inc. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $8.97K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Provectus Biopharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Provectus Biopharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Pershing Edward | CEO | – | Sep 18, 2026 | 37 |
| Rodrigues Dominic | PRESIDENT | – | Jun 30, 2026 | 1 |
| Lacey John III | Director | – | Jun 30, 2026 | 1 |
| Bailey Webster | Director | – | Jun 30, 2026 | 1 |
| Wachter Eric PhD | CTO | – | Dec 4, 2024 | 0 |
| Raines Heather | CFO | – | Dec 4, 2024 | 0 |
| Morris Jeffrey Allen | 10% Owner | 4,260,061 | Aug 14, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 11, 2026 (view filing) | Feb 9 | 2 days | Pershing EdwardCEO | PPurchase | +349.4K | $0.286 | +$99.9K | –2.61M after | Derivative |
| Nov 25, 2024 (view filing) | Nov 22 | 3 days | Pershing EdwardCEO | PPurchase | +803.6K | $0.286 | +$229.8K | –1.69M after | Derivative |
| Oct 19, 2023 (view filing)5:16 PM ET | Oct 3 | 16 daysLate | Pershing EdwardDirector | PPurchase | +193.1K | $0.2862 | +$55.3K | –690.8K after | Derivative |
| Sep 20, 2022 (view filing)5:26 PM ET | Sep 16 | 4 days | Rodrigues DominicDirector | PPurchase | +11.4M | $0.2862 | +$3.27M | –11.4M after | Derivative |